-
1
-
-
33344458573
-
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
-
Miyakis S Lockshin MD Atsumi T et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemostas 2006; 4: 295-306.
-
(2006)
J Thromb Haemostas
, vol.4
, pp. 295-306
-
-
Miyakis, S.1
Lockshin, M.D.2
Atsumi, T.3
-
2
-
-
0028810205
-
Criteria for the diagnosis of lupus anticoagulants: An update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardization Committee of the ISTH
-
Brandt JT Triplett DA Alving B Scharrer I. Criteria for the diagnosis of lupus anticoagulants: An update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardization Committee of the ISTH. Thromb Haemost. 1995; 74: 1185-1190.
-
(1995)
Thromb Haemost.
, vol.74
, pp. 1185-1190
-
-
Brandt, J.T.1
Triplett, D.A.2
Alving, B.3
Scharrer, I.4
-
3
-
-
0030885477
-
Antiphospholipid syndrome without antiphospholipid antibodies at the time of the thrombotic event: Transient 'seronegative' antiphospholipid syndrome
-
Miret C Cervera R Reverter JC et al. Antiphospholipid syndrome without antiphospholipid antibodies at the time of the thrombotic event: transient 'seronegative' antiphospholipid syndrome. Clin Exp Rheumatol 1997; 15: 541-544.
-
(1997)
Clin Exp Rheumatol
, vol.15
, pp. 541-544
-
-
Miret, C.1
Cervera, R.2
Reverter, J.C.3
-
4
-
-
1942532181
-
Seronegative antiphospholipid syndrome
-
Hughes GR Khamashta MA. Seronegative antiphospholipid syndrome. Ann Rheum Dis 2004; 63: 608.
-
(2004)
Ann Rheum Dis
, vol.63
, pp. 608
-
-
Hughes, G.R.1
Khamashta, M.A.2
-
5
-
-
50249103825
-
The primary, secondary, catastrophic, and seronegative variants of the antiphospholipid syndrome: A personal history long in the making
-
Asherson RA. The primary, secondary, catastrophic, and seronegative variants of the antiphospholipid syndrome: A personal history long in the making. Semin Thromb Hemost 2008; 34: 227-235.
-
(2008)
Semin Thromb Hemost
, vol.34
, pp. 227-235
-
-
Asherson, R.A.1
-
6
-
-
0025951058
-
Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin
-
Bevers EM Galli M Barbui T Comfurius P Zwaal RF. Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemost 1991; 66: 629-632.
-
(1991)
Thromb Haemost
, vol.66
, pp. 629-632
-
-
Bevers, E.M.1
Galli, M.2
Barbui, T.3
Comfurius, P.4
Zwaal, R.F.5
-
7
-
-
0027253088
-
Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: An explanation for their pathogenic mechanism
-
Oosting JD Derksen RH Bobbink IW Hackeng TM Bouma BN de Groot PG. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: An explanation for their pathogenic mechanism. Blood 1993; 81: 2618-2625.
-
(1993)
Blood
, vol.81
, pp. 2618-2625
-
-
Oosting, J.D.1
Derksen, R.H.2
Bobbink, I.W.3
Hackeng, T.M.4
Bouma, B.N.5
de Groot, P.G.6
-
8
-
-
1542373659
-
Antibodies to tissue-type plasminogen activator (tPA) in patients with antiphospholipid syndrome: Evidence of interaction between the antibodies and the catalytic domain of tPA in 2 patients
-
Cugno M Cabibbe M Galli M et al. Antibodies to tissue-type plasminogen activator (tPA) in patients with antiphospholipid syndrome: Evidence of interaction between the antibodies and the catalytic domain of tPA in 2 patients. Blood 2004; 103: 2121-2126.
-
(2004)
Blood
, vol.103
, pp. 2121-2126
-
-
Cugno, M.1
Cabibbe, M.2
Galli, M.3
-
9
-
-
0034030512
-
Antibodies to tissue-type plasminogen activator in plasma from patients with primary antiphospholipid syndrome
-
Cugno M Dominguez M Cabibbe M et al. Antibodies to tissue-type plasminogen activator in plasma from patients with primary antiphospholipid syndrome. Br J Haematol 2000; 108: 871-875.
-
(2000)
Br J Haematol
, vol.108
, pp. 871-875
-
-
Cugno, M.1
Dominguez, M.2
Cabibbe, M.3
-
10
-
-
34147213486
-
Factor XII autoantibodies as a novel marker for thrombosis and adverse obstetric history in patients with systemic lupus erythematosus
-
Bertolaccini ML Mepani K Sanna G Hughes GR Khamashta MA. Factor XII autoantibodies as a novel marker for thrombosis and adverse obstetric history in patients with systemic lupus erythematosus. Ann Rheum Dis 2007; 66: 533-536.
-
(2007)
Ann Rheum Dis
, vol.66
, pp. 533-536
-
-
Bertolaccini, M.L.1
Mepani, K.2
Sanna, G.3
Hughes, G.R.4
Khamashta, M.A.5
-
11
-
-
0025828109
-
Guidelines for testing and revised criteria for lupus anticoagulants
-
SSC Subcommittee for the Standardization of Lupus Anticoagulants
-
Exner T Triplett DA Taberner D Machin SJ. Guidelines for testing and revised criteria for lupus anticoagulants. SSC Subcommittee for the Standardization of Lupus Anticoagulants. Thromb Haemost 1991; 65: 320-322.
-
(1991)
Thromb Haemost
, vol.65
, pp. 320-322
-
-
Exner, T.1
Triplett, D.A.2
Taberner, D.3
Machin, S.J.4
-
12
-
-
0026072735
-
Guidelines on testing for the lupus anticoagulants
-
Lupus Anticoagulant Working Party
-
Lupus Anticoagulant Working Party. Guidelines on testing for the lupus anticoagulants. J Clin Pathol 1991; 44: 885-889.
-
(1991)
J Clin Pathol
, vol.44
, pp. 885-889
-
-
-
13
-
-
0004750551
-
Guidelines of the investigation and management of the antiphospholipid syndrome
-
Greaves M Cohen H MacHin SJ Mackie I. Guidelines of the investigation and management of the antiphospholipid syndrome. Br J Haematol 2000; 109: 704-715.
-
(2000)
Br J Haematol
, vol.109
, pp. 704-715
-
-
Greaves, M.1
Cohen, H.2
MacHin, S.J.3
Mackie, I.4
-
14
-
-
0030982684
-
Potentially clinically important inaccuracies in testing for the lupus anticoagulant: An analysis of results from three surveys of the UK National External Quality Assessment Scheme (NEQAS) for Blood Coagulation
-
Jennings I Kitchen S Woods TA Preston FE Greaves M. Potentially clinically important inaccuracies in testing for the lupus anticoagulant: An analysis of results from three surveys of the UK National External Quality Assessment Scheme (NEQAS) for Blood Coagulation. Thromb Haemost 1997; 77: 934-937.
-
(1997)
Thromb Haemost
, vol.77
, pp. 934-937
-
-
Jennings, I.1
Kitchen, S.2
Woods, T.A.3
Preston, F.E.4
Greaves, M.5
-
15
-
-
0033035842
-
Lupus anticoagulant testing in Europe: An analysis of results from the first European Concerted Action on Thrombophilia (ECAT) survey using plasmas spiked with monoclonal antibodies against human beta2-glycoprotein I
-
Arnout J Meijer P Vermylen J. Lupus anticoagulant testing in Europe: An analysis of results from the first European Concerted Action on Thrombophilia (ECAT) survey using plasmas spiked with monoclonal antibodies against human beta2-glycoprotein I. Thromb Haemost 1999; 81: 929-934.
-
(1999)
Thromb Haemost
, vol.81
, pp. 929-934
-
-
Arnout, J.1
Meijer, P.2
Vermylen, J.3
-
16
-
-
0036440669
-
Lupus anticoagulant testing: Improvements in performance in a UK NEQAS proficiency testing exercise after dissemination of national guidelines on laboratory methods
-
UK National External Quality Assessment Scheme for Blood Coagulation
-
Jennings I Greaves M Mackie IJ Kitchen S Woods TA Preston FE; UK National External Quality Assessment Scheme for Blood Coagulation. Lupus anticoagulant testing: Improvements in performance in a UK NEQAS proficiency testing exercise after dissemination of national guidelines on laboratory methods. Br J Haematol 2002; 119: 364-369.
-
(2002)
Br J Haematol
, vol.119
, pp. 364-369
-
-
Jennings, I.1
Greaves, M.2
Mackie, I.J.3
Kitchen, S.4
Woods, T.A.5
Preston, F.E.6
-
17
-
-
13244292384
-
Lupus anticoagulant testing using plasma spiked with monoclonal antibodies: Performance in the UK NEQAS proficiency testing programme
-
UK National External Quality Assessment Scheme for Blood Coagulation
-
Jennings I Mackie I Arnout J Preston FE.; UK National External Quality Assessment Scheme for Blood Coagulation. Lupus anticoagulant testing using plasma spiked with monoclonal antibodies: Performance in the UK NEQAS proficiency testing programme. J Thromb Haemost 2004; 2: 2178-2184.
-
(2004)
J Thromb Haemost
, vol.2
, pp. 2178-2184
-
-
Jennings, I.1
Mackie, I.2
Arnout, J.3
Preston, F.E.4
-
18
-
-
53049097739
-
A consensus approach to the formulation of guidelines for laboratory testing and reporting of antiphospholipid antibody assays
-
Wong RC Favaloro EJ. A consensus approach to the formulation of guidelines for laboratory testing and reporting of antiphospholipid antibody assays. Semin Thromb Hemost 2008; 34: 361-372.
-
(2008)
Semin Thromb Hemost
, vol.34
, pp. 361-372
-
-
Wong, R.C.1
Favaloro, E.J.2
-
19
-
-
68949173102
-
Update of the guidelines for measuring the presence of Lupus Anticoagulant
-
(submitted for publication)
-
Pengo V; Tripodi A; Reber G; et al. Update of the guidelines for measuring the presence of Lupus Anticoagulant (submitted for publication).
-
-
-
Pengo, V.1
Tripodi, A.2
Reber, G.3
-
20
-
-
0026793768
-
Anticoagulant activity of β2-glycoprotein I is potentiated by a distinct subgroup of anticardiolipin antibodies
-
Galli M Comfurius P Barbui T Zwaal RFA Bevers EM. Anticoagulant activity of β2-glycoprotein I is potentiated by a distinct subgroup of anticardiolipin antibodies. Thromb Haemost 1992; 68: 297-300.
-
(1992)
Thromb Haemost
, vol.68
, pp. 297-300
-
-
Galli, M.1
Comfurius, P.2
Barbui, T.3
Zwaal, R.F.A.4
Bevers, E.M.5
-
21
-
-
0031968872
-
The contribution of anti-prothrombin antibodies to the lupus anticoagulant activity - Discrimination between functional and non-function anti-prothrombin antibodies
-
Horbach DA van Oort E Derksen RHWM de Groot PG. The contribution of anti-prothrombin antibodies to the lupus anticoagulant activity - Discrimination between functional and non-function anti-prothrombin antibodies. Thromb Haemost 1998; 79: 790-795.
-
(1998)
Thromb Haemost
, vol.79
, pp. 790-795
-
-
Horbach, D.A.1
van Oort, E.2
Derksen, R.H.W.M.3
de Groot, P.G.4
-
22
-
-
0142197160
-
A simple method to discriminate between β2-glycoprotein I and prothrombin-dependent lupus anticoagulants
-
Simmelink MJ Derksen RHWM Arnout JM de Groot PG. A simple method to discriminate between β2-glycoprotein I and prothrombin-dependent lupus anticoagulants. J Thromb Haemost 2003; 1: 740-747.
-
(2003)
J Thromb Haemost
, vol.1
, pp. 740-747
-
-
Simmelink, M.J.1
Derksen, R.H.W.M.2
Arnout, J.M.3
de Groot, P.G.4
-
23
-
-
3242741348
-
A two-step coagulation test to identify aβ2-glycoprotein I lupus antcoagulants
-
Pengo V Biasiolo A Pegoraro C Iliceto S. A two-step coagulation test to identify aβ2-glycoprotein I lupus antcoagulants. J Thromb Haemost 2004; 2: 702-707.
-
(2004)
J Thromb Haemost
, vol.2
, pp. 702-707
-
-
Pengo, V.1
Biasiolo, A.2
Pegoraro, C.3
Iliceto, S.4
-
24
-
-
7044223470
-
β2-glycoprotein I-dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndrome
-
De Laat HB Derksen RHWM Urbanus RT Roest M de Groot PG. β2-glycoprotein I-dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndrome. Blood 2004; 104: 3598-3602.
-
(2004)
Blood
, vol.104
, pp. 3598-3602
-
-
De Laat, H.B.1
Derksen, R.H.W.M.2
Urbanus, R.T.3
Roest, M.4
de Groot, P.G.5
-
25
-
-
13544276197
-
IgG antibodies that recognize epitope Gly40-Arg43 in domain I of β2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis
-
De Laat B Derksen RHWM Urbanus RT de Groot PG. IgG antibodies that recognize epitope Gly40-Arg43 in domain I of β2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis. Blood 2005; 105: 1540-1545.
-
(2005)
Blood
, vol.105
, pp. 1540-1545
-
-
De Laat, B.1
Derksen, R.H.W.M.2
Urbanus, R.T.3
de Groot, P.G.4
-
26
-
-
33846936761
-
Correlation between antiphospholipid antibodies that recognize domain I of beta2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5
-
De Laat B Wu XX van Lummel M Derksen RH de Groot PG Rand JH. Correlation between antiphospholipid antibodies that recognize domain I of beta2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5. Blood 2007; 109: 1490-1494.
-
(2007)
Blood
, vol.109
, pp. 1490-1494
-
-
De Laat, B.1
Wu, X.X.2
van Lummel, M.3
Derksen, R.H.4
de Groot, P.G.5
Rand, J.H.6
-
27
-
-
57149100983
-
Correlation between the potency of a beta2-glycoprotein I-dependent lupus anticoagulant and the level of resistance to activated protein C
-
De Laat B Eckmann CM van Schagen M Meijer AB Mertens K van Mourik JA. Correlation between the potency of a beta2-glycoprotein I-dependent lupus anticoagulant and the level of resistance to activated protein C. Blood Coagul Fibrinolysis 2008; 19: 757-764.
-
(2008)
Blood Coagul Fibrinolysis
, vol.19
, pp. 757-764
-
-
De Laat, B.1
Eckmann, C.M.2
van Schagen, M.3
Meijer, A.B.4
Mertens, K.5
van Mourik, J.A.6
-
28
-
-
0037370733
-
Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: A systematic review of the literature
-
Galli M Luciani D Bertolini G Barbui T. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: A systematic review of the literature. Blood 2003; 101: 1827-1832.
-
(2003)
Blood
, vol.101
, pp. 1827-1832
-
-
Galli, M.1
Luciani, D.2
Bertolini, G.3
Barbui, T.4
-
29
-
-
0036896088
-
Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus
-
Somers E Magder LS Petri M. Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus. J Rheumatol 2002; 29: 2531-2536.
-
(2002)
J Rheumatol
, vol.29
, pp. 2531-2536
-
-
Somers, E.1
Magder, L.S.2
Petri, M.3
-
31
-
-
0037111360
-
Prevalence and clinical features of dementia associated with the antiphospholipid syndrome and circulating anticoagulants
-
Chapman J Abu-Katash M Inzelberg R. Prevalence and clinical features of dementia associated with the antiphospholipid syndrome and circulating anticoagulants. J Neurol Sci 2002; 203-204: 81-84.
-
(2002)
J Neurol Sci
, vol.203-204
, pp. 81-84
-
-
Chapman, J.1
Abu-Katash, M.2
Inzelberg, R.3
-
33
-
-
12544253380
-
Predictors of cognitive dysfunction in patients with systemic lupus erythematosus
-
Mc Laurin EY Holliday SL Williams P Brey RL. Predictors of cognitive dysfunction in patients with systemic lupus erythematosus. Neurology 2005; 64: 297-303.
-
(2005)
Neurology
, vol.64
, pp. 297-303
-
-
Mc Laurin, E.Y.1
Holliday, S.L.2
Williams, P.3
Brey, R.L.4
-
34
-
-
0021029327
-
Anticardiolipin antibodies: Detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus
-
Harris EN Gharavi AE Boey ML et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet. 1983; 2: 1211-1214.
-
(1983)
Lancet
, vol.2
, pp. 1211-1214
-
-
Harris, E.N.1
Gharavi, A.E.2
Boey, M.L.3
-
35
-
-
0023860688
-
Use of an enzyme-linked immunosorbent assay and of inhibition studies to distinguish between antibodies to cardiolipin from patients with syphilis or autoimmune disorders
-
Harris EN Gharavi AE Wasley GD Hughes GR. Use of an enzyme-linked immunosorbent assay and of inhibition studies to distinguish between antibodies to cardiolipin from patients with syphilis or autoimmune disorders. J Infect Dis 1988; 157: 23-31.
-
(1988)
J Infect Dis
, vol.157
, pp. 23-31
-
-
Harris, E.N.1
Gharavi, A.E.2
Wasley, G.D.3
Hughes, G.R.4
-
36
-
-
0025302635
-
Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor
-
Galli M Comfurius P Maassen C. et al Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990; 335: 1544-1547.
-
(1990)
Lancet
, vol.335
, pp. 1544-1547
-
-
Galli, M.1
Comfurius, P.2
Maassen, C.3
-
37
-
-
0025195938
-
Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease
-
Matsuura E Igarashi Y Fujimoto M Ichikawa K Koike T. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 1990; 336: 177-178.
-
(1990)
Lancet
, vol.336
, pp. 177-178
-
-
Matsuura, E.1
Igarashi, Y.2
Fujimoto, M.3
Ichikawa, K.4
Koike, T.5
-
38
-
-
13244255285
-
Should our approach to the anticardiolipin assay change 20 years after its discovery
-
Meroni PL Tincani A. Should our approach to the anticardiolipin assay change 20 years after its discovery. J Thromb Haemost 2004; 2: 1074-1076.
-
(2004)
J Thromb Haemost
, vol.2
, pp. 1074-1076
-
-
Meroni, P.L.1
Tincani, A.2
-
40
-
-
0025500242
-
The second international anti-cardiolipin standardization workshop/The Kingstone anti-phospholipid antibody study (KAPS) Group
-
Harris EN. The second international anti-cardiolipin standardization workshop/The Kingstone anti-phospholipid antibody study (KAPS) Group. Am J Clin Pathol 1990; 94: 476-484.
-
(1990)
Am J Clin Pathol
, vol.94
, pp. 476-484
-
-
Harris, E.N.1
-
41
-
-
0028083763
-
Fifth international symposium on antiphospholipid antibodies
-
Anticardiolipin Wet Workshop Report
-
Harris EN Pierangeli S Birch D. Anticardiolipin Wet Workshop Report. Fifth international symposium on antiphospholipid antibodies. Am J Clin Pathol 1994; 101: 616-624.
-
(1994)
Am J Clin Pathol
, vol.101
, pp. 616-624
-
-
Harris, E.N.1
Pierangeli, S.2
Birch, D.3
-
42
-
-
7044260448
-
Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies
-
Tincani A Allegri F Balestrieri G et al. Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies. Thromb Res 2004; 114: 553-558.
-
(2004)
Thromb Res
, vol.114
, pp. 553-558
-
-
Tincani, A.1
Allegri, F.2
Balestrieri, G.3
-
43
-
-
10744227266
-
Consensus guidelines on anti-cardiolipin antibody testing and reporting
-
Wong RCW Gillis D Adelstein S et al. Consensus guidelines on anti-cardiolipin antibody testing and reporting. Pathology 2004; 36: 63-68.
-
(2004)
Pathology
, vol.36
, pp. 63-68
-
-
Wong, R.C.W.1
Gillis, D.2
Adelstein, S.3
-
44
-
-
0036180864
-
Recent advances in antiphospholipid antibodies and antiphospholipid syndrome in pediatric populations
-
Avcin T Cimaz R Meroni PL. Recent advances in antiphospholipid antibodies and antiphospholipid syndrome in pediatric populations. Lupus 2002; 11: 4-10.
-
(2002)
Lupus
, vol.11
, pp. 4-10
-
-
Avcin, T.1
Cimaz, R.2
Meroni, P.L.3
-
45
-
-
0032499659
-
Antiphospholipid syndrome in the elderly: Caution
-
Piette JC Cacoub MD. Antiphospholipid syndrome in the elderly: Caution. Circulation 1998; 97: 2195-2196.
-
(1998)
Circulation
, vol.97
, pp. 2195-2196
-
-
Piette, J.C.1
Cacoub, M.D.2
-
46
-
-
0030854659
-
Prevalence of anticardiolipin and antinuclear antibodies in an elderly hospitalized population and mortality after a 6-year follow-up
-
De Moerloose P Boehlen F Reber G Dechevrens O Herrmann F Michel JP. Prevalence of anticardiolipin and antinuclear antibodies in an elderly hospitalized population and mortality after a 6-year follow-up. Age Ageing 1997; 26: 319-320.
-
(1997)
Age Ageing
, vol.26
, pp. 319-320
-
-
De Moerloose, P.1
Boehlen, F.2
Reber, G.3
Dechevrens, O.4
Herrmann, F.5
Michel, J.P.6
-
47
-
-
0034903945
-
Anticardiolipin antibody assay: A methodological analysis for a better consensus in routine determinations. A cooperative project of the European Antiphospholipid Forum
-
Tincani A Allegri F Sanmarco M et al. Anticardiolipin antibody assay: A methodological analysis for a better consensus in routine determinations. A cooperative project of the European Antiphospholipid Forum. Thromb Haemost 2001; 86: 575-583.
-
(2001)
Thromb Haemost
, vol.86
, pp. 575-583
-
-
Tincani, A.1
Allegri, F.2
Sanmarco, M.3
-
48
-
-
33747182601
-
V Meeting of the European Forum on Antiphospholipid Antibodies
-
Cervera R Font J Tincani A Boffa MC. V Meeting of the European Forum on Antiphospholipid Antibodies. Autoimmun Rev 2006; 5: 499-507.
-
(2006)
Autoimmun Rev
, vol.5
, pp. 499-507
-
-
Cervera, R.1
Font, J.2
Tincani, A.3
Boffa, M.C.4
-
49
-
-
0028934121
-
Multicenter evaluation of nine commercial kits for the quantitation of anticardiolipin antibodies
-
The Working Group on Methodologies in Haemostasis from the GEHT (Groupe d'Estudes sur l'Hémostase et la Thrombose)
-
Reber G Arvieux J Comby E et al. Multicenter evaluation of nine commercial kits for the quantitation of anticardiolipin antibodies. The Working Group on Methodologies in Haemostasis from the GEHT (Groupe d'Estudes sur l'Hémostase et la Thrombose). Thromb Haemost 1995; 73: 444-452.
-
(1995)
Thromb Haemost
, vol.73
, pp. 444-452
-
-
Reber, G.1
Arvieux, J.2
Comby, E.3
-
50
-
-
33344458573
-
International consensus statement on an update of the classification criteria for define antiphospholipid syndrome (APS)
-
Miyakis S Atsumi T Lockshin MD et al. International consensus statement on an update of the classification criteria for define antiphospholipid syndrome (APS). J Thrombos Haemostas 2006; 4: 295-306.
-
(2006)
J Thrombos Haemostas
, vol.4
, pp. 295-306
-
-
Miyakis, S.1
Atsumi, T.2
Lockshin, M.D.3
-
51
-
-
0019938113
-
Chlorpromazine-induced lupus anticoagulant and associated immunologic abnormalities
-
Canoso RT Sise HS. Chlorpromazine-induced lupus anticoagulant and associated immunologic abnormalities. Am J Hematol 1982; 13: 121-129.
-
(1982)
Am J Hematol
, vol.13
, pp. 121-129
-
-
Canoso, R.T.1
Sise, H.S.2
-
52
-
-
0025028903
-
Beta 2-glycoprotein I for binding of anticardiolipin antibodies to cardiolipin
-
Bevers EM Galli M. Beta 2-glycoprotein I for binding of anticardiolipin antibodies to cardiolipin. Lancet 1990; 336: 952-953.
-
(1990)
Lancet
, vol.336
, pp. 952-953
-
-
Bevers, E.M.1
Galli, M.2
-
53
-
-
0026000561
-
Measurement of antiphospholipid antibodies by ELISA using β2-glycoprotein I as an antigen
-
Arvieux J Roussel B Jacob MC Colomb MG. Measurement of antiphospholipid antibodies by ELISA using β2-glycoprotein I as an antigen. J Immunol Methods 1991; 143: 223-229.
-
(1991)
J Immunol Methods
, vol.143
, pp. 223-229
-
-
Arvieux, J.1
Roussel, B.2
Jacob, M.C.3
Colomb, M.G.4
-
54
-
-
0036305202
-
Inter-laboratory variability of anti-β2-glycoprotein I measurement
-
Reber G Schousboe I Tincani A. Inter-laboratory variability of anti-β2-glycoprotein I measurement. Thromb Haemost 2002; 88: 66-73.
-
(2002)
Thromb Haemost
, vol.88
, pp. 66-73
-
-
Reber, G.1
Schousboe, I.2
Tincani, A.3
-
56
-
-
13244292209
-
Proposals for the measurement of anti-β2-glycoprotein I antibodies. Standardization group of the European Forum on Antiphospholipid Antibodies
-
Reber G Tincani A Sanmarco M de Moerloose P Boffa MC. Proposals for the measurement of anti-β2-glycoprotein I antibodies. Standardization group of the European Forum on Antiphospholipid Antibodies. J Thromb Haemost 2004; 2: 1860-1862.
-
(2004)
J Thromb Haemost
, vol.2
, pp. 1860-1862
-
-
Reber, G.1
Tincani, A.2
Sanmarco, M.3
de Moerloose, P.4
Boffa, M.C.5
-
57
-
-
12344309367
-
Heterogeneity of anti-beta2-glycoprotein I antibodies. A factor of variability in test results
-
Sanmarco M Bardin N Blank M et al. Heterogeneity of anti-beta2-glycoprotein I antibodies. A factor of variability in test results. Thromb Haemost 2005; 93: 80-87.
-
(2005)
Thromb Haemost
, vol.93
, pp. 80-87
-
-
Sanmarco, M.1
Bardin, N.2
Blank, M.3
-
58
-
-
0030589375
-
The anti-β2-Glycoprotein I activity in human anti-phospholipid syndrome sera is due to monoreactive low-affinity autoantibodies directed to epitopes located on native β2-glycoprotein I and preserved during species' evolution
-
Tincani A Spatola L Prati E et al. The anti-β2-Glycoprotein I activity in human anti-phospholipid syndrome sera is due to monoreactive low-affinity autoantibodies directed to epitopes located on native β2-glycoprotein I and preserved during species' evolution. J Immunol 1996; 157: 5732-5738.
-
(1996)
J Immunol
, vol.157
, pp. 5732-5738
-
-
Tincani, A.1
Spatola, L.2
Prati, E.3
-
59
-
-
18844400656
-
Budding, vesiculation, permeabilization of phospholipids membrane-evidence for a feasible. Physiologic role of β2-glycoprotein I and pathogenic action of anti-β2-glycoprotein I antibodies
-
Ambrozic A; Bozic B; Kveder T; et al. Budding, vesiculation, permeabilization of phospholipids membrane-evidence for a feasible. Physiologic role of β2-glycoprotein I and pathogenic action of anti-β2-glycoprotein I antibodies. Biochim Biophys Acta 2005; 1740: 38-44.
-
(2005)
Biochim Biophys Acta
, vol.1740
, pp. 38-44
-
-
Ambrozic, A.1
Bozic, B.2
Kveder, T.3
-
60
-
-
7244255874
-
High avidity anti-beta 2-glycoprotein I antibodies in patients with antiphospholipid syndrome
-
Cucnik S Kveder T Krizaj I Rozman B Bozic B. High avidity anti-beta 2-glycoprotein I antibodies in patients with antiphospholipid syndrome. Ann Rheum Dis 2004; 63: 1478-1482.
-
(2004)
Ann Rheum Dis
, vol.63
, pp. 1478-1482
-
-
Cucnik, S.1
Kveder, T.2
Krizaj, I.3
Rozman, B.4
Bozic, B.5
-
61
-
-
28744436571
-
Antigenic structures recognized by anti- beta2-glycoprotein I autoantibodies
-
Kasahara H Matsura E Kaihara K et al. Antigenic structures recognized by anti- beta2-glycoprotein I autoantibodies. Int Immunol 2005; 17: 1533-1542.
-
(2005)
Int Immunol
, vol.17
, pp. 1533-1542
-
-
Kasahara, H.1
Matsura, E.2
Kaihara, K.3
-
62
-
-
62749204448
-
Sixth meeting of the European Forum on antiphospholipid antibodies. How to improve the understanding of the antiphospholipid syndrome
-
Rotar Z Rozman B de Groot PG et al. Sixth meeting of the European Forum on antiphospholipid antibodies. How to improve the understanding of the antiphospholipid syndrome. Lupus. 2009; 18: 53-60.
-
(2009)
Lupus
, vol.18
, pp. 53-60
-
-
Rotar, Z.1
Rozman, B.2
de Groot, P.G.3
|